Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.48 |
| ▸ | HTR2A | P28223 | 2/20 | 0.44 |
| ▸ | HTR2C | P28335 | 2/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.39 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9669413 | 0.92 | KCNN4 (0.52) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL10349268 | 0.85 | CACNA1C (0.40) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL9067519 | 0.85 | KCNN4 (0.52) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL414397 | 0.80 | ALDH1A1 (0.50) | KCNN4KMT2ATSHRMEN1CYP1A2 | |
| SCHEMBL9626191 | 0.78 | ALDH1A1 (0.46) | KCNN4KMT2ATSHRMEN1CYP1A2 | |
| SCHEMBL10350145 | 0.78 | KCNN4 (0.46) | KCNN4OPRK1KCNH2KMT2ATSHR | |
| SCHEMBL10349828 | 0.78 | ALDH1A1 (0.37) | KMT2AMEN1CYP1A2CA2CHRM2 | |
| SCHEMBL11251144 | 0.76 | CYP19A1 (0.47) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL11248026 | 0.76 | CYP19A1 (0.47) | KCNN4HTR2AHTR2COPRK1KCNH2 | |
| SCHEMBL11246284 | 0.75 | CYP19A1 (0.36) | KCNN4HTR2AHTR2COPRK1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1676478-B1 | Slime remover and slime preventing/removing agent | NIPPON SODA CO (JP) | 2011-08-24 | — | — | EP | claimed |
| US-7727692-B2 | Electrophotographic photoreceptor, image forming apparatus, and process cartridge | FUJI XEROX CO., LTD. (JP) | 2010-06-01 | — | — | US | claimed |
| US-7098174-B2 | Slime remover and slime preventing/removing agent | NIPPON SODA CO., LTD. (JP) | 2006-08-29 | — | — | US | claimed |
| EP-1676478-A2 | Slime remover and slime preventing/removing agent | NIPPON SODA CO., LTD. (JP) | 2006-07-05 | — | — | EP | claimed |
| US-6927199-B2 | Slime remover and slime preventing/removing agent containing a clathrate compound | NIPPON SODA CO., LTD (JP) | 2005-08-09 | — | — | US | claimed |
| EP-0923867-B1 | Antimicrobial compositions and their use | KURITA WATER IND LTD (JP) | 2003-11-05 | — | — | EP | claimed |
| US-20030032569-A1 | Slime remover and slime preventing/removing agent | NIPPON SODA CO., LTD. | 2003-02-13 | — | — | US | claimed |
| EP-1113112-A1 | SLIME REMOVER AND SLIME PREVENTING/REMOVING AGENT | NIPPON SODA CO., LTD. (JP) | 2001-07-04 | — | — | EP | claimed |
| EP-0923867-A1 | Antimicrobial composition and their use | KURITA WATER INDUSTRIES LTD. (JP) | 1999-06-23 | — | — | EP | claimed |
| JP-8053304-A | — | — | None | — | — | JP | disclosed |
| JP-1292200-A | — | — | None | — | — | JP | disclosed |
| JP-62142130-A | — | — | None | — | — | JP | disclosed |
| US-20160166526-A1 | COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-06-16 | — | — | US | disclosed |
| EP-2528598-B1 | COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI - CANCER AGENT | TAKEDA PHARMACEUTICAL (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-5041620-A | Method for producing optically active 2-cyclopenten-4-one-1-ol esters, 2-cyclopenteno-4-one-1-ol ester and complexes thereof with optically active 1,6-diphenyl-2,4-hexadiyne-1,6-diol | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-08-20 | — | — | US | disclosed |
| EP-0220887-B1 | METHOD OF OPTICALLY RESOLVING A RACEMATE OR A DIASTEREOMERIC MIXTURE OF GLYCIDYL COMPOUND | Daiso Co., Ltd. (JP) | 1990-06-27 | — | — | EP | disclosed |
| JP-H01292200-A | PAPER-LIKE PRODUCT | KURITA WATER IND LTD | 1989-11-24 | — | — | JP | disclosed |
| US-4841081-A | Method of optically resolving a racemate or a diastereomeric mixture of glycidyl compound | OSAKA SODA CO., LTD. (JP) | 1989-06-20 | — | — | US | disclosed |
| JP-S62142130-A | OPTICALLY ACTIVE CYCLOPENTENONE ESTER COMPLEX AND ITS PREPARATION | SUMITOMO CHEM CO LTD | 1987-06-25 | — | — | JP | disclosed |
| EP-0220887-A1 | Method of optically resolving a racemate or a diastereomeric mixture of glycidyl compound | Daiso Co., Ltd. (JP) | 1987-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166526-A1 | COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT | PMP22, GAP43, NGF | KCNN4 1554/4885HTR2A 3384/4885HTR2C 4164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.